Sarepta Therapeutics, Inc. SRPT Accrued Progress Collections and Price Adjustments
Accrued Progress Collections and Price Adjustments at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s accrued progress collections and price adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s accrued progress collections and price adjustments?
- Sarepta Therapeutics, Inc. (SRPT) reported accrued progress collections and price adjustments of $136.35M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s accrued progress collections and price adjustments changed year-over-year?
- Sarepta Therapeutics, Inc.'s accrued progress collections and price adjustments decreased by 58.0% year-over-year, from $325M to $136.35M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s accrued progress collections and price adjustments?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s accrued progress collections and price adjustments has grown at a -33.9% compound annual growth rate (CAGR), from $663.49M to $83.91M.